REG - Yooma Wellness Inc. - Vitality CBD Novel Foods Update

Yooma WellnessAnnouncement

01/04/2022 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220401:nRSA8619Ga&default-theme=true

RNS Number : 8619G  Yooma Wellness Inc.  01 April 2022

1 April 2022

 

Yooma Wellness Inc.

('Yooma' or the 'Company' or the 'Group')

 

Vitality CBD Novel Foods Update

Vitality products have successfully been added to the register

 

Yooma Wellness Inc. (CSE:YOOM; AQSE:YOOM), a global vertically integrated
wellness platform that develops and markets a portfolio of CBD and wellness
brands, is pleased to announce that the Company's wholly owned subsidiary,
Vitality CBD and its extensive product range have successfully been published
on the UK Food Standard Agencies (FSA) Novel Foods approved list for CBD.

 

The increased compliance in the sector is welcomed by the Company, which helps
ensure that only fully compliant products are available for purchase. Those
not included on the FSA's CBD Novel Food register will subsequently have to be
taken off sale.

 

Phillip Glyn, Commercial Director of Vitality, said: "After 18 months of work
and investment, Vitality CBD is delighted and proud to be included on the
Novel Food Public List. It is an important milestone for the Company and will
add further credibility to being one of the most trusted CBD brands in the
UK."

 

Jordan Greenberg, CEO of Yooma, said: "Yesterday's update by the FSA is
welcome news and moves us ever closer to receiving full authorisation for
Vitality's products. Yooma's position as a vertically-integrated manufacturer
and distributor of CBD products means we are well placed to capitalise on the
growing demand for these products across the UK and Europe. We look forward to
receiving the results of the toxicology report and updating shareholders on
our further progress."

 

About Vitality CBD Limited

Vitality CBD (https://vitalitycbd.co.uk/) is the most widely stocked brand of
CBD in the UK with products distributed in national retailers such as Boots,
Tesco, ASDA and Lloyds Pharmacy. Vitality CBD is also prominent on E-commerce
retailers such as Amazon, eBay, Very & Ocado. The Vitality CBD product
portfolio has over 60 SKUs including oils and sprays in a wide range of
flavours and strengths, edibles, and a specially developed and formulated
range of CBD skin care cosmetic products.

 

About Yooma Wellness Inc.

Yooma's mission is to build a vertically-integrated global leader in the
manufacturing, marketing, distribution, and sale of wellness products
including hemp seed oil and hemp-derived and cannabinoid (CBD) ingredients.
 The Company leverages strategically curated sales channels and ecommerce
networks to deliver a diverse mix of wellness products through operating
subsidiaries in the United States, United Kingdom, France and Japan.  Learn
more at www.yooma.ca (http://www.yooma.ca) .

 

- Ends -

 

The directors of the company accept responsibility for the contents of this
announcement.

 For further information, please contact:

 Yooma Wellness Inc.                        Via Buchanan

 Jordan Greenberg

 AQSE Corporate Adviser:

 Peterhouse Capital Limited                 Tel: +44 (0) 20 7469 0930

 Guy Miller / Mark Anwyl                    Tel: +44 (0) 7990 139 093

 Media Enquiries                            Tel: +44 (0) 20 7466 5000

 Buchanan                                   yooma@buchanan.uk.com (mailto:yooma@buchanan.uk.com)

 Henry Harrison-Topham / Jamie Hooper

 Ariadna Peretz / George Beale

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXUAUKRUBUOOAR